WHO AND AFRICA CDC BOOST MPOX VACCINATION CAMPAIGN ACROSS 17 AFRICAN NATIONS

In a strong, united response to the spread of mpox, the World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) are launching enhanced vaccination efforts across Nigeria and 16 other African countries. This initiative, which kicked off in early November, is focused on developing effective, targeted vaccination plans to maximize the impact of the limited vaccine doses available.

Between November 5 and 7, 2024, health experts and officials from 17 African countries gathered in Brazzaville, Congo, to devise strategies tailored to the specific needs of each region. Representatives from WHO, Africa CDC, and major partners, including Gavi, the Vaccine Alliance, UNICEF, and the U.S. Centers for Disease Control and Prevention, engaged in discussions to ensure the vaccination campaigns are directed towards those most at risk. This effort aims to reduce the spread of the virus through efficient, focused vaccine deployment in areas with significant mpox cases.

Dr. Matshidiso Moeti, WHO Regional Director for Africa, emphasized the urgency of these vaccination campaigns, noting that traditional public health measures have proven challenging in containing the virus. Dr. Moeti highlighted the importance of preparing and implementing swift, efficient vaccination plans to protect vulnerable communities and prevent further transmission.

The targeted countries include Burundi, Cameroon, Central African Republic, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Ghana, Guinea, Liberia, Kenya, Nigeria, Republic of Congo, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. Each of these nations has seen a rise in mpox cases, underscoring the need for a coordinated, continent- wide response.

This collaborative effort between WHO, Africa CDC, and partner organizations reflects a deep commitment to the health and safety of African communities. By focusing on data- driven vaccination strategies, these campaigns are expected to make a significant impact, curbing the spread of mpox and protecting at-risk populations.

As the vaccination plans roll out, public health officials hope this initiative will play a crucial role in managing the outbreak across Africa. Through international collaboration and targeted action, Africa’s health agencies are taking proactive steps to secure a healthier future for the continent.